Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 7/20 | 0.49 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.47 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.47 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | IGF2R | P11717 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28582954 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7549022 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7570192 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7568898 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7568905 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7569083 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7568791 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7541741 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7541384 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 | |
| SCHEMBL7549016 | 1.00 | P2RY14 (0.49) | P2RY14B4GALT1P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002048331-A2 | ACTIVE-SITE ENGINEERING OF NUCLEOTIDYLTRANSFERASES AND ENZYMATIC METHODS FOR THE SYNTHESIS OF NATURAL AND 'UNNATURAL' UDP- AND NUCLEOTIDE SUGARS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2002-06-20 | — | — | WO | claimed |
| WO-2002079150-A2 | GLYCORANDOMIZATION AND THE PRODUCTION OF NOVEL ERYTHRONOLIDE AND COUMARIN ANALOGS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2002-10-10 | — | — | WO | disclosed |